This week's infographic looks at sector allocation across the leading European healthcare real estate investors, drawn from HBI's Healthcare Property Investors Ranking.
Sunway Group, one of Malaysia’s largest construction groups owned by billionaire Jeffrey Cheah, is proceeding with the IPO of its healthcare arm, Sunway Healthcare Holdings (SHH). The IPO aims to raise at least 2.86 billion ringgit (~$736 million) and could be the largest Malaysian listing in nearly a decade.
EuroEyes Netherlands, part of the EuroEyes International Eye Clinic group, a Germany-based ophthalmology company, has agreed to acquire Dutch refractive surgery provider FYEO for an enterprise value of €135 million.
Kooth is a UK-based digital mental health company that provides free-at-the-point-of-use (publicly reimbursed) support to teenagers and young people in the UK and the US. In a recent conversation with HBI, Kate Newhouse, CEO, explained the company’s ethos and why there is such a need for the kind of early-intervention mental health services it provides.
The merger of two of Europe’s largest healthcare REITs, Aedifica and Cofinimmo, will proceed after Cofinimmo shareholders representing 79.54% of its shares agreed to tender these at an exchange rate of 1.185 newly created Aedifica shares per Cofinimmo share.
American private equity firm GI Partners has agreed to acquire the contract development and manufacturing organisation (CDMO) and cell solutions businesses of Charles River Laboratories as part of a broader portfolio reshuffle by the global contract research organisation (CRO).
FutureLife Group, a pan-European provider of IVF and genetics services co-owned by Luxembourg-based private equity firm CVC Capital Partners and Central Europe-based Hartenberg Holding, has acquired UK-based IVF clinic Herts & Essex Fertility Centre.
Swedish private equity firm EQT has confirmed its intention to drop the takeover bid for UK-based Contract Development Manufacturing Organisation (CDMO) Oxford Biomedica (OXB).
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
